FINRA has authorized the broker-dealer subsidiary of Ondo Finance to offer access to NMS equities, ETFs, mutual funds, index funds, and more.
Oasis Pro Markets, a broker-dealer subsidiary of Ondo Finance, has received approval from the Financial Industry Regulatory Authority (FINRA), a self-regulatory organization (SRO) for U.S. broker-dealers, to offer tokenized corporate equities and funds to U.S. financial institutions and American retail investors, officials say.
Under the oversight of the Securities and Exchange Commission (SEC) and FINRA, the tokenized instruments are available via over-the-counter (OTC) markets, underwritten primary offerings, private placements, and through other avenues, officials say.
“These authorizations build upon Ondo’s acquisition of Oasis Pro, which owns an SEC-registered broker-dealer, an SEC-registered alternative trading system (ATS), and an SEC-registered transfer agent. Oasis Pro’s transfer agent, Oasis Pro TA, provides support for digital asset transfer agent services, such as on-chain capitalization table management, shareholder rights, and cross-asset collateral mobility,” officials say.
The new framework will allow Oasis Pro Markets to “offer U.S. investors market access to NMS equities, fund interests such as ETFs, mutual funds, and index funds, and securities issued through IPOs and traded in secondary markets,” officials say. “Settlement for these assets can occur with fiat currencies or supported stablecoins, including directly between blockchain-based wallets.”
The regulatory approvals “allow Ondo’s Oasis Pro Markets to support omnibus account structures through integrations with existing broker-dealer and advisory channels. This will enable institutional investors, registered investment advisers, and retirement accounts to access tokenized securities through their current brokers,” officials add.
Oasis Pro Markets LLC is an SEC-registered broker-dealer and ATS, and a member of FINRA/SIPC, officials say. Oasis Pro TA LLC is an SEC-registered transfer agent.
Is your company featured in this article? Contact us about reprints or licensing.
Leave a Reply